Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A rare presentation of BCR‐ABL1 and RUNX1‐MECOM rearrangement in a pediatric patient with acute myeloid leukemia

1 May 2024

Abstract excerpt

Key Clinical Message In a patient with de novo AML, co‐existing BCR::ABL1 p190 isoform and RUNX1::MECOM rearrangement is accompanied by a very poor prognosis including limited response to treatment and no molecular remission. It is essential to develop a consensus on the therapeutic modalities different from the current regimen. Abstract Acquisition of BCR::ABL1 fusion as a primary or secondary event and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Multiple Myeloma Research and Treatments
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38751957
DOI: 10.1002/ccr3.8917

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A rare presentation of BCR‐ABL1 and RUNX1‐MECOM rearrangement in a pediatric patient with acute myeloid leukemiaPMID 38751957Read ↗

Acute myeloid leukemia with rare recurring translocations—an overview of the entities included in the international consensus classificationSemantic proximity Read ↗

Genetic Profile, Treatment Response, and Outcomes of BCR::ABL1-Positive Mixed-Phenotype Acute Leukemia: A Study From the BCR::ABL1 Pathology Group.Semantic proximity Read ↗

BCR-ABL-positive acute myeloid leukemia: a new entity? Analysis of clinical and molecular features.Semantic proximity Read ↗

Myeloproliferative neoplasm with ETV6-ABL1 fusion: a case report and literature reviewSemantic proximity Read ↗

Clinical and genomic characterization of patients diagnosed with the provisional entity acute myeloid leukemia with BCR-ABL1, a Swedish population-based study.Semantic proximity Read ↗

A rare BCR-ABL1 transcript in Philadelphia-positive acute myeloid leukemia: case report and literature reviewSemantic proximity Read ↗

A Case of AML1/ETO Positive Child with Acute Myeloid Leukemia with Poor Prognosis.Semantic proximity Read ↗

AML with CBFB–MYH11 rearrangement demonstrate RAS pathway alterations in 92% of all cases including a high frequency of NF1 deletionsSemantic proximity Read ↗

AML with 11q23/MLL abnormalities as defined by the WHO classification: incidence, partner chromosomes, FAB subtype, age distribution, and prognostic impact in an unselected series of 1897 cytogenetically analyzed AML casesSemantic proximity Read ↗

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.Semantic proximity Read ↗

Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1.Semantic proximity Read ↗

Rare and novel RUNX1 fusions in myeloid neoplasms: A single-institute experience.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.